Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Swati Gupta and Mr. Marc Dixneuf discuss how to broaden global advocacy and increase investment for an HIV vaccine.Presenters:Swati Gupta, DrPH, MPHVice President and Head of Emerging Infectious Diseases and Scientific StrategyInternational AIDS Vaccine InitiativeNew York, New YorkMarc Dixneuf, PhDDirector GeneralAIDESPantin, FranceSpecial Commentator:  Jonathan Weber, MB, BChir, PhD, FRCP, FRCPath, FMed SciDean of the Faculty of MedicineImperial CollegeLondon, United KingdomLink to full series:https://bit.ly/3ytytMYLink to the HIV unmuted series from IAS:https://bit.ly/3f5qC0dContent is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.

In this episode, Jehan Budak, MD, discusses the use of HIV-ASSIST, a free, online, decision-support tool to inform ART selection.Jehan Budak, MDAssistant ProfessorDivision of Allergy & Infectious DiseasesUniversity of WashingtonSeattle, WashingtonContent based on a CME program supported by educational grants from Gilead Sciences, Inc.; Theratechnologies; and ViiV Healthcare.Link to full program:https://bit.ly/33RZ9Zy

In this episode, Latesha Elopre, MD, MSPH, explains how to initiate pre-exposure prophylaxis (PrEP), including in underserved communities, with examples on overcoming barriers and improving access.Listen as she gives her perspectives on:Evidence for PrEP efficacy in the DISCOVER studyRecommendations in MSM, heterosexual men and women, injection drug users, and adolescents and adults weighing more than 77 lbCDC guidanceHow PrEP is underused, including racial/ethnic disparitiesStrategies to overcoming barriersPresenter:Latesha Elopre, MD, MSPHAssistant ProfessorDivision of Infectious DiseasesDirector of Diversity and InclusionGeneral Medical EducationUniversity of Alabama at BirminghamBirmingham, AlabamaFollow along with the slides at:https://bit.ly/3ABCNL8See the entire program at:https://bit.ly/2TXTYWx 

In this episode, Daniel J. Kuritzkes, MD, reviews key clinical trial data and gives practical insights such as how to initiate a patient on long-acting therapy, recommended dosing regimens, and factors that may increase the risk of treatment failure. The overview will include analyses of:ATLAS and FLAIR studies of long-acting injectable CAB + RPVATLAS 2M dosing studyFDA approval and DHHS statement on use of long-acting injectable ARTStudies on whether an oral lead-in is neededPresenter:Daniel R. Kuritzkes, MDChief, Division of Infectious DiseasesBrigham and Women’s HospitalHarriet Ryan Albee Professor of MedicineHarvard Medical SchoolBoston, MassachusettsFollow along with the slides at:https://bit.ly/3hNfHIISee the entire program at:https://bit.ly/2TXTYWx 

In this episode, Joseph J. Eron, Jr., MD, and Darcy Wooten, MD, share insights on HIV antiretroviral therapy safety and tolerability including recent data on weight gain and metabolic implications with INSTIs and NRTIs as well as the latest updates and recommendations on dolutegravir and pregnancy.Joseph J. Eron, Jr., MDProfessor of Medicine and EpidemiologyUniversity of North Carolina School of MedicineDirector, AIDS Clinical Trials UnitUniversity of North CarolinaChapel Hill, North CarolinaDarcy Wooten, MDAssociate Professor of MedicineDivision of Infectious Diseases and Global Public HealthDepartment of MedicineUniversity of California, San DiegoSan Diego, CaliforniaContent based on a CME program supported by independent educational grants from Janssen Therapeutics, Division of Janssen Products, LP, and ViiV HealthcareLink to full program:https://bit.ly/3ydMtcL

Listen to expert insights from Joseph J. Eron, Jr., MD, on exciting data about investigational agents (dapivirine ring, islatravir, lenacapavir, broadly neutralizing antibodies) for next-generation HIV prevention.Joseph J. Eron, Jr., MDProfessor of Medicine and EpidemiologyUniversity of North Carolina School of MedicineDirector, AIDS Clinical Trials UnitUniversity of North CarolinaChapel Hill, North CarolinaLink to full program:https://bit.ly/3ux6FF8

Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Susan Buchbinder and Mr. Jontraye Davis discuss what has been learned and built through the past 40 years of HIV vaccine research, including how HIV vaccine scientific advancements and infrastructure were critical to the success of developing a COVID-19 vaccine.Presenters:Susan Buchbinder, MDClinical ProfessorDepartments of Medicine, Epidemiology and BiostatisticsUniversity of California, San FranciscoDirector, Bridge HIVSan Francisco Department of Public HealthSan Francisco, California  Jontraye Davis, MHA, PMD ProCommunity Program Manager FHI 360Adjunct InstructorNorth Carolina Central UniversityDurham, North CarolinaSpecial Commentator:  Jerome H. Kim, MDDirector GeneralInternational Vaccine InstituteSeoul, South KoreaLink to full series:https://bit.ly/3ytytMYLink to the HIV unmuted series from IAS:https://bit.ly/3f5qC0dContent is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.

In this episode, David A. Wohl, MD, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV.David A. Wohl, MD    Professor of MedicineSchool of MedicineSite Leader, AIDS Clinical Trials Unit-Chapel HillUniversity of North Carolina at Chapel HillDirector, North Carolina AIDS Training and Education CenterChapel Hill, North CarolinaCo-Director, HIV ServicesNorth Carolina Department of CorrectionRaleigh, North CarolinaLink to full program:https://bit.ly/3ux6FF8

In this episode, Roger Bedimo, MD, MS, FACP; Princy N. Kumar,  MD, FIDSA, MACP; and Brian Wood, MD, answer healthcare professionals’ most pressing questions on caring for heavily treatment–experienced patients with HIV.Faculty:Roger Bedimo, MD, MS, FACP  Professor of MedicineDivision of Infectious DiseasesUniversity of Texas Southwestern Medical CenterSection ChiefDivision of Infectious DiseasesDepartment of Internal MedicineVA North Texas Health Care SystemDallas, TexasPrincy N. Kumar, MD, FIDSA, MACPProfessor of Medicine and MicrobiologyChief, Division of Infectious Diseases and Tropical MedicineSenior Associate Dean of StudentsGeorgetown University School of MedicineWashington, DCBrian Wood, MDAssociate Professor of MedicineDivision of Allergy and Infectious DiseasesUniversity of WashingtonSeattle, WashingtonContent based on an online CME/CPE-certified program supported by educational grant from ViiV Healthcare.Link to full program:https://bit.ly/3g8aBHs

In this episode, the first in a yearlong series on Key Decisions in HIV Care, Daniel R. Kuritzkes, MD, and Chloe Orkin, MBChB, FRCP, MD, discuss important considerations when switching ART in patients with viral suppression on their current regimen, including guideline recommendations and data supporting different switch regimen options such as single-tablet triple therapy, 2-drug oral regimens, doravirine-based regimens, and long-acting injectable therapy. Following their dialogue, the faculty field questions from healthcare professionals.Presenters:Daniel R. Kuritzkes, MDChief, Division of Infectious  DiseasesBrigham and Women's HospitalHarriet Ryan Albee Professor of MedicineHarvard Medical SchoolBoston, MassachusettsChloe Orkin, MBChB, FRCP, MDProfessor of HIV  Queen Mary, University of LondonConsultant PhysicianLead for HIV ResearchBarts Health NHS TrustThe Royal London HospitalLondon, United KingdomContent based on an online CME program supported by educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; and ViiV Healthcare.Link to full program:https://bit.ly/2TXTYWx

Listen to expert insights from W. David Hardy, MD, on current options for pre-exposure prophylaxis and exciting new data on next-generation HIV prevention.W. David Hardy, MDScientific and Medical ConsultantAdjunct Clinical Professor of MedicineDivision of Infectious DiseasesKeck School of Medicine of USCLos Angeles, CaliforniaContent based on a CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:https://bit.ly/3ux6FF8

Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this first episode, Dr. Linda-Gail Bekker and Ms. Maureen Luba discuss why an HIV vaccine remains the ultimate game-changer to ending the epidemic and the gaps it will address in the expanding HIV prevention landscape.Presenters:Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD  Chief Operating Officer  Desmond Tutu HIV Foundation  Deputy DirectorDesmond Tutu HIV Centre  Past PresidentInternational AIDS Society  Faculty of Health Sciences  University of Cape Town  Cape Town, South AfricaMaureen LubaAfrica Region Advocacy AdvisorGlobal Advocacy for HIV PreventionAIDS Vaccine Advocacy CoalitionLink to full series:https://bit.ly/3ytytMYLink to the HIV unmuted series from IAS:https://bit.ly/3f5qC0dContent is part of a CME-certified educational program that is supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare. 

In this episode, Daniel R. Kuritzkes, MD, and Michelle S. Cespedes, MD, MS, discuss new ART data from virtual CROI 2021.Michelle S. Cespedes, MD, MSAssociate Professor of MedicineDivision of Infectious DiseaseDepartment of MedicineIcahn School of Medicine at Mount SinaiAttending PhysicianMount Sinai Medical CenterNew York, New YorkDaniel R. Kuritzkes, MD  Chief, Division of Infectious DiseasesBrigham and Women’s HospitalProfessor of MedicineHarvard Medical SchoolBoston, MassachusettsContent based on a CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:https://bit.ly/3ux6FF8

In this episode, Ethel D. Weld, MD, PhD, demonstrates the use of HIV-ASSIST, a free, online, decision support tool to inform ART selection.Ethel D. Weld, MD, PhDAssistant Professor of Medicine, Pharmacology, & Molecular SciencesDivision of Clinical PharmacologyDepartment of Infectious DiseasesJohns Hopkins University School of MedicineAttending PhysicianInpatient HIV ServiceGeneral Infectious Diseases Consult ServicesJohns Hopkins HospitalBaltimore, MarylandContent based on a CME program supported by educational grants from Gilead Sciences, Inc.; Theratechnologies; and ViiV Healthcare.Link to full program:https://bit.ly/33RZ9Zy

In episode 3 of an ongoing series of sharing sessions between a physician and patient, Jordan J. Feld, MD, MPH, and Wendy, who is living with chronic hepatitis B, discuss the challenges of determining the best time to start treatment. The conversation focuses on incorporating shared decision-making, particularly for cases that are not straight forward and do not fit into an one specific category outlined by the guidelines.  Presenter:Jordan J. Feld, MD, MPHAssociate Professor of MedicineUniversity of TorontoHepatologistToronto Centre for Liver DiseaseSandra Rotman Centre for Global HealthToronto, CanadaContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3u196yK

In this episode, William R. Short, MD, MPH, AAHIVS, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV.William R. Short, MD, MPH, AAHIVSAssociate Professor of MedicineDivision of Infectious DiseasesDepartment of Medicine  Perelman School of Medicine at the University of PennsylvaniaPhiladelphia, PennsylvaniaContent based on a CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:https://bit.ly/3ux6FF8

In Part 4 of this 4-part series, listen to Howard Grossman, MD, and Cristina Mussini, MD, answer healthcare professionals’ questions on vaccine recommendations, bone health and fragility fractures, and racial disparities and social determinants that affect caring for patients aging with HIV.Presenters:Howard Grossman, MDClinical Affiliate Assistant ProfessorDepartment of Integrated Medical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityBoca Raton, FloridaMedical Director, West Palm Beach, Wilton Manors, and Key WestMidway Specialty CareWilton Manors, FloridaCristina Mussini, MDHead, Department of Infectious Diseases and Tropical MedicineFull Professor of Infectious DiseaseInfectious Disease Clinics, University HospitalUniversity of Modena and Reggio EmiliaModena, Italy  Content based on an online CME/CE/CPE-certified program supported by educational grants from Gilead Sciences, Inc.; Merck Sharp & Dohme Corp.; and ViiV Healthcare.  Link  to full program:http://bit.ly/32JD145

In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss simplification strategies for a virologically suppressed patient with HIV and a complex ART treatment history.Presenters:José R. Arribas, MDResearch Director, HIV and Infectious DiseasesHospital La Paz IdiPAZMadrid, SpainAndrew Carr, MBBS, MD, FRACP, FRCPAProfessor of MedicineUniversity of New South WalesDirector, HIV and Immunology UnitSt Vincent’s HospitalSydney, AustraliaLynora Saxinger, MD, FRCPC, CTropMedCochair, Scientific Advisory GroupAlberta COVID-19 EmergencyCoordination CentreAssociate ProfessorDivision of Infectious DiseasesDepartment of MedicineUniversity of AlbertaEdmonton, AlbertaCanadaContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program:https://bit.ly/3xdgcTk

In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss ART safety and management in a woman who wishes to conceive.Presenters:José R. Arribas, MDResearch Director, HIV and Infectious DiseasesHospital La Paz IdiPAZMadrid, SpainAndrew Carr, MBBS, MD, FRACP, FRCPAProfessor of MedicineUniversity of New South WalesDirector, HIV and Immunology UnitSt Vincent’s HospitalSydney, AustraliaLynora Saxinger, MD, FRCPC, CTropMedCochair, Scientific Advisory GroupAlberta COVID-19 EmergencyCoordination CentreAssociate ProfessorDivision of Infectious DiseasesDepartment of MedicineUniversity of AlbertaEdmonton, AlbertaCanadaContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program:https://bit.ly/3xdgcTk

In this episode, Drs José R. Arribas, Andrew Carr, and Lynora Saxinger discuss weight gain concerns for a patient with initiating ART.Presenters:José R. Arribas, MDResearch Director, HIV and Infectious DiseasesHospital La Paz IdiPAZMadrid, SpainAndrew Carr, MBBS, MD, FRACP, FRCPAProfessor of MedicineUniversity of New South WalesDirector, HIV and Immunology UnitSt Vincent’s HospitalSydney, AustraliaLynora Saxinger, MD, FRCPC, CTropMedCochair, Scientific Advisory GroupAlberta COVID-19 EmergencyCoordination CentreAssociate ProfessorDivision of Infectious DiseasesDepartment of MedicineUniversity of AlbertaEdmonton, AlbertaCanadaContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program:https://bit.ly/3xdgcTk

In episode 2 of an ongoing series of sharing sessions between a physician and patient, Robert Gish, MD, FAASLD, and patient advocate, Alan Wang, discuss stigma as a barrier to optimal HBV care and treatment. The conversation focuses on how stigma affected Alan’s engagement with his care and strategies to overcome stigma as a barrier to HBV care.Presenter:Robert Gish, MD, FAASLD Medical DirectorHepatitis B FoundationMedical DirectorAsian Pacific Health Foundation San Diego, CaliforniaContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3u196yK

In episode 1 of this ongoing series, listen to a conversation between Grace LH Wong, MD, and her patient, Ms. Chan, on the shared decision for Ms. Chan to start treatment for hepatitis B infection during her pregnancy.Presenter:Grace LH Wong, MDProfessorDivision of Gastroenterology and HepatologyDepartment of Medicine and TherapeuticsThe Chinese University of Hong KongHonorary ConsultantDivision of Gastroenterology and HepatologyDepartment of Medicine and TherapeuticsPrince of Wales HospitalHong KongContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3u196yK

In this episode, Chloe Orkin, MBChB, FRCP, MD, discusses exciting new HIV data reported at the virtual CROI 2021, including new findings on HIV PrEP, HIV and COVID-19, ART in pregnancy and the postpartum period, as well as on the comparative efficacy of various ARV regimens.Presenter:Chloe Orkin, MBChB, FRCP, MDProfessor of HIV  Queen Mary University of LondonConsultant Physician  Lead for HIV Research  Barts Health NHS TrustThe Royal London HospitalLondon, United KingdomContent based on a CME program supported by educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.Link to full program:http://bit.ly/3eUPAj9 

In episode 17 of this series, Arthur Kim, MD, provides a brief update on the latest COVID-19 treatment options and guidelines. After the update, Dr. Kim answers questions submitted by healthcare professionals on various aspects of COVID-19.  Presenter:Arthur Kim, MDAssociate ProfessorDepartment of MedicineHarvard Medical SchoolDirector, Viral Hepatitis ClinicDivision of Infectious DiseasesMassachusetts General HospitalBoston, Massachusetts  Content based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0

In this episode, Dr. Bekker discusses results from key studies reported at the 4th HIV Research for Prevention Conference (HIVR4P // Virtual), including results from studies evaluating novel approaches to HIV prevention such as broadly neutralizing antibodies, long-acting injectable and oral ARVs, and implantable options. In addition, Dr. Bekker will discuss several studies evaluating different aspects of PrEP implementation and acceptance as well as considerations for multipurpose prevention strategies.  Presenter:Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD  DirectorDesmond Tutu HIV CentrePast PresidentInternational AIDS SocietyFaculty of Health SciencesUniversity of Cape TownCape Town, South AfricaContent based on a CME program supported by independent educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; Merck Sharp & Dohme Corp; and ViiV Healthcare.Link to full program:http://bit.ly/3s41GtM 

In this episode, Dr. Jens Lundgren discusses results from key studies reported at the IAS COVID-19 Conference: Prevention, including new findings on potential SARS-CoV-2 suppressive therapies, strategies for vaccination and mass testing, and interventions to prevent transmission of COVID-19 while maintaining desired outcomes in HIV care.Jens D. Lundgren, MD, DMScProfessorRigshospitalet, University of CopenhagenCopenhagen, DenmarkDirectorCentre of Excellence for Health, Immunity and Infection (CHIP)Rigshospitalet, University of CopenhagenCopenhagen, Denmark Content based on a CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program:http://bit.ly/3avWfhs

In this episode, Part 16 of an ongoing series, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, provides a brief update on emerging COVID-19 variants and their potential impacts on vaccine efficacy. After the update, Professor Lewin answers questions submitted by healthcare professionals on various aspects of COVID-19. Presenter:Sharon R. Lewin, AO, FRACP, PhD, FAHMSDirector, The Peter Doherty Institute for Infection and ImmunityMelbourne Laureate Professor of Infectious Diseases University of MelbourneConsultant Infectious Diseases PhysicianAlfred Hospital and Royal Melbourne HospitalMelbourne, AustraliaContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0

In this episode, Part 3 of a 4-part series, Dr. Monica Gandhi, Dr. Rajesh Gandhi, and Dr. Josep Llibre discuss key health challenges faced by aging patients with HIV and answer clinicians’ questions on HIV treatment considerations and on prevention, screening, and treatment of common age-related comorbidities.Presenters:Monica Gandhi, MD, MPHProfessor of MedicineDivision of HIV, Infectious Diseases, and Global MedicineUniversity of California, San FranciscoMedical DirectorWard 86 HIV ClinicSan Francisco General HospitalSan Francisco, CaliforniaRajesh T. Gandhi, MDProfessor of MedicineDepartment of Infectious DiseasesHarvard Medical SchoolPhysician, Infectious DiseasesMassachusetts General HospitalBoston, MassachusettsJosep M. Llibre, MD, PhDSenior Consultant Physician and Clinical ResearcherDepartment of Infectious DiseasesLluita Contra La SIDA FoundationUniversity Hospital, Germans Trias i PujolBadalonaBarcelona, SpainContent based on an online CME/CE/CPE-certified program supported by educational grants from Gilead Sciences, Inc., Merck Sharp & Dohme Corp., and ViiV Healthcare.Link  to full program:http://bit.ly/32JD145

In this episode, Part 15 of an ongoing series, Roger Paredes, MD, PhD, provides a brief update on emerging COVID-19 variants and their potential impacts on the pandemic. After the update, Dr. Paredes answers clinician questions on various aspects of COVID-19.  Presenter:Roger Paredes, MD, PhDSection Chief, Infectious Diseases DepartmentGermans Trias i Pujol University Hospital Head of the Microbial Genomics Group IrsiCaixa AIDS Research InstituteBadalona, Catalonia, SpainContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0 

In this episode, Part 14 of an ongoing series, Vikramjit Mukherjee, MD, provides a brief update on COVID-19 mortality trends, including the latest data on overall and in-hospital fatality rates. After the update, Dr. Mukherjee answers clinician questions on various aspects of COVID-19. Presenter:Vikramjit Mukherjee, MDAssistant Professor of MedicineDivision of Pulmonary, Critical Care, and Sleep MedicineNew York University School of MedicineDirector, Medical Intensive Care UnitBellevue HospitalNew York, New YorkContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:http://bit.ly/3eDoJF0

In this episode, Joseph J. Eron, Jr., MD; and Daniel R. Kuritzkes, MD; discuss evolving issues in first-line antiretroviral therapy, including 2-drug therapy, weight gain, and safety during conception and pregnancy.Presenters:Joseph J. Eron, Jr., MDProfessor of Medicine and EpidemiologyUniversity of North Carolina School of MedicineDirector, AIDS Clinical Trials UnitUniversity of North CarolinaChapel Hill, North CarolinaDaniel R. Kuritzkes, MDChief, Division of Infectious DiseasesBrigham and Women’s HospitalHarriet Ryan Albee Professor of MedicineHarvard Medical SchoolBoston, MassachusettsContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:http://bit.ly/34fVILZ

In this episode, the third in a 3-part series on Ending the HIV Epidemic,  Judith Feinberg, MD, and  Kenneth Mayer, MD, discuss the important role of HIV pre-expsoure prophylaxis (PrEP) for preventing HIV infection among at-risk individuals and critical strategies for effective PrEP implementation among principle populations, including men who have sex with men and transgender women, heterosexual cisgender women, and people who inject drugs. Following their dialogue, the faculty field clinician questions on HIV prevention.Presenters:Judith Feinberg, MDProfessorAttending PhysicianDepartments of Medicine and Behavioral Medicine & PsychiatryWest Virginia University School of MedicineMorgantown, West VirginiaKenneth Mayer, MDInfectious Disease AttendingBeth Israel Deaconess Medical CenterProfessor of MedicineHarvard Medical SchoolMedical Research DirectorFenway Community HealthBoston, MassachusettsContent based on an online CME program supported by educational grants from Gilead Sciences and ViiV Healthcare and produced in collaboration with PCE and HealthHIV.Link to full program:http://bit.ly/3263Q1s

In this episode, Roger Bedimo, MD, MS, FACP, and Eric S. Daar, MD, discuss caring for heavily treatment–experienced patients with HIV, including assessment of virologic failure and current treatment options for patients with multiclass drug resistance.Presenters:Roger Bedimo, MD, MS, FACP Professor of MedicineDivision of Infectious Diseases University of Texas Southwestern Medical Center Section ChiefDivision of Infectious Diseases Department of Internal Medicine VA North Texas Health Care System Dallas, TexasEric S. Daar, MDChiefDivision of HIV Medicine Harbor-UCLA Medical Center Professor of MedicineDavid Geffen School of Medicine at UCLA Los Angeles, CaliforniaContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:http://bit.ly/34fVILZ

In this episode, Part 13 of an ongoing series, Jens D. Lundgren, MD, DMSc, provides a brief update monoclonal antibody treatments for COVID-19, including the FDA Emergency Use Authorization for bamlanivimab and discusses the recently released information on COVID-19 vaccine efficacy. After the update, Professor Lundgren answers clinician questions on various aspects of COVID-19. Presenter:Jens D. Lundgren, MD, DMScProfessorRigshospitalet, University of CopenhagenCopenhagen, DenmarkDirectorCentre of Excellence for Health, Immunity and Infection (CHIP)Rigshospitalet, University of CopenhagenCopenhagen, DenmarkContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0

In this episode, the second in a 3-part series on Ending the HIV Epidemic, Jason Halperin, MD, MPH, and Aadia I. Rana, MD, discuss treatment as prevention, the critical infrastructure needed to implement rapid ART, the importance of routinely assessing for barriers to care, and real-time monitoring strategies that improve patient adherence and engagement. Following their dialogue, the faculty field clinician questions on HIV treatment and retention in care.Presenters:Jason Halperin, MD, MPHAssistant Professor of MedicineDepartment of Infectious DiseasesTulane UniversityInfectious Disease PhysicianCrescentCareNew Orleans, LouisianaAadia I. Rana, MDAssociate Professor of MedicineDivision of Infectious Diseases The University of Alabama at Birmingham 1917 ClinicBirmingham, AlabamaContent based on an online CME program supported by educational grants from Gilead Sciences and ViiV Healthcare and produced in collaboration with PCE and HealthHIV.Link to full program:https://bit.ly/3263Q1s

In this episode, Dr. Terrault discusses results from key viral hepatitis studies reported at the American Association for the Study of LiverDiseases (AASLD) 2020 annual conference, The Liver Meeting Digital Experience, including new findings on HBV treatment and management, hepatocellular carcinoma risk, and emerging approaches to HCV care in underserved populations.Presenter:Norah Terrault, MD, MPHProfessor of MedicineChief of Gastrointestinal and Liver DiseasesUniversity of Southern CaliforniaLos Angeles, CaliforniaContent based on a CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program: https://bit.ly/37bBrce

In this episode, Brian Wood, MD, discusses HIV treatment safety and tolerability data from 2020 conferences and addresses how he manages ARV-associated weight gain his patients and how the latest data on ART safety during conception and pregnancy impact his treatment recommendations.Presenters:Brian Wood, MDAssociate Professor of MedicineDivision of Allergy and Infectious DiseasesUniversity of WashingtonSeattle, WashingtonContent based on an online CME/CE/CPE-certified program supported by educational grants from Janssen Therapeutics, Division of Janssen Products, LP.Link to full program:https://bit.ly/38YZVrz

In this episode, Part 2 of an 4-part series, Dr. Jonathan Appelbaum, Dr. Howard Grossman, and Professor Jürgen Rockstroh discuss key health challenges faced by aging patients with HIV and answer clinicians’ questions on HIV treatment considerations and on prevention, screening, and treatment of common age-related comorbidities.Presenters:Jonathan Appelbaum MD, FACP, AAHIVSLaurie L. Dozier Jr, MD, Education DirectorProfessor of MedicineChair, Department of Clinical SciencesFlorida State University College of MedicineTallahassee, FloridaHoward Grossman, MDClinical Affiliate Assistant ProfessorDepartment of Integrated Medical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityBoca Raton, FloridaMedical Director, West Palm Beach, Wilton Manors, and Key WestMidway Specialty CareWilton Manors, FloridaJürgen Rockstroh, MDProfessor of MedicineUniversity of BonnBonn, GermanyContent based on an online CME/CE/CPE-certified program supported by educational grants from Gilead Sciences, Inc., Merck Sharp & Dohme Corp., and ViiV Healthcare.Link to full program:https://bit.ly/32JD145

In this episode, Dr. Joseph Eron and Dr. Jason Halperin discuss caring for complex HIV cases, including patients with underlying resistance or comorbidities.Presenters:Joseph J. Eron, Jr., MDProfessor of Medicine and EpidemiologyUniversity of North Carolina School of MedicineDirector, AIDS Clinical Trials UnitUniversity of North CarolinaChapel Hill, North CarolinaJason Halperin, MD, MPHAssistant Professor of MedicineDepartment of Infectious DiseasesTulane UniversityInfectious Disease PhysicianCrescentCareNew Orleans, LouisianaContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.Link to full program:https://bit.ly/34fVILZ

In this episode, Part 12 of an ongoing series, David Heymann, BA, MD, DTM&H, provides a brief update on strategies for moving forward and living safely within the continued COVID-19 pandemic. After the update, Professor Heymann answers clinician questions on various aspects of COVID-19. Presenter:David Heymann, BA, MD, DTM&H Professor of Infectious Disease EpidemiologyLondon School of Hygiene & Tropical MedicineLondon, EnglandContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0

In this episode, the first in a 3-part series on Ending the HIV Epidemic, Lisa K. Fitzpatrick, MD, MPH, MPA, and David Malebranche, MD, MPH, discuss strategies to expand early HIV testing, maximize patient engagement in HIV care, navigate emerging clusters of HIV infection, and combat HIV-related stigma. Following their dialogue, the faculty field clinician questions on HIV diagnosis and management.  Presenters:Lisa K. Fitzpatrick, MD, MPH, MPAProfessorial LecturerDepartment of EpidemiologyGeorge Washington University School of Public HealthInterim Medical DirectorBlueRock CareWashington, DCDavid J. Malebranche, MD, MPHBoard-Certified Internal Medicine PhysicianHIV SpecialistContent based on an online CME program supported by educational grants from Gilead Sciences and ViiV Healthcare and produced in collaboration with PCE and HealthHIV.Link to full program:https://bit.ly/3263Q1s   

In this episode, Dr. Gandhi discusses results from key studies reported at the virtual IDWeek 2020 conference, including new findings on transmission in different settings, symptom progression and clinical outcomes, detection of non-SARS-CoV-2 viruses during the pandemic, and treatment and prevention strategies.Presenter:Rajesh T. Gandhi, MD Professor of Medicine  Department of Infectious DiseasesHarvard Medical SchoolPhysician, Infectious DiseasesMassachusetts General HospitalBoston, MassachusettsContent based on a CME program supported by an independent educational grant from  Gilead Sciences, Inc.Link to full program:https://bit.ly/35HxQS8 

In this episode, Part 11 of an ongoing series, Sharon R. Lewin AO, FRACP, PhD, FAHMS, provides a brief update on the role of interferons in COVID-19. After the update, Dr. Lewin answers clinician questions on various aspects of COVID-19. Presenter:Sharon R. Lewin AO, FRACP, PhD, FAHMSDirector, The Peter Doherty Institute for Infection and ImmunityMelbourne Laureate Professor of Infectious Diseases University of MelbourneConsultant Infectious Diseases PhysicianAlfred Hospital and Royal Melbourne HospitalContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0

In this episode, Dr. Sherer discusses results from key studies reported at the 2020 International Congress on Drug Therapy in HIV Infection (HIV Glasgow 2020 Virtual), including studies on long-term 2-drug and 3-drug antiretroviral therapy, newer 3-drug regimens in patients with baseline NRTI resistance, investigational HIV treatment approaches, and important comoribidities in patients with HIV, including COVID-19.Presenter:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineUniversity of ChicagoChicago, IllinoisContent based on a CME program supported by independent educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP, and ViiV Healthcare.Link to full program:https://bit.ly/35nGqph

In this episode, Part 10 of an ongoing series, Wong Chen Seong, MBBS, MRCP(UK), FAMS, provides a brief update on COVID-19 and HIV. After the update, Dr. Wong answers clinician questions on various aspects of COVID-19.Presenter:Wong Chen Seong, MBBS, MRCP(UK), FAMSHead, NCID Clinical HIV ProgrammeDeputy Director, National HIV ProgrammeNational Centre for Infectious Diseases ConsultantDepartment of Infectious DiseasesTan Tock Seng Hospital Programme DirectorNHG Infectious Diseases Residency ProgrammeAdjunct Assistant ProfessorYong Loo Lin School of MedicineNational University of SingaporeSingaporeContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0

In this episode, Dr. Rath discusses results from key studies reported at the European Society of Clinical Microbiology and Infectious Diseases Conference on Corona Virus Disease (ECCVID), including studies on COVID-19 screening and diagnostics, vaccines, prevention strategies, social disparities, and therapeutics.Presenter:Barbara Rath, MD, PhD, HDR Co-founder & Chair The Vienna Vaccine Safety InitiativeResearch DirectorUniversité de Bourgogne Franche-Comté, FranceHonorary ProfessorExecutive Board MemberESGREV (Respiratory Virus Study Group for ESCMID) Content based on CME program supported by an independent educational grant from Merck & Co., Inc.Link to full program:https://bit.ly/37e6Hcc

In this episode, Part 9 of an ongoing series, Lynora Saxinger, MD, FRCPC, CTropMed, provides a brief update on key concepts in COVID-19 immunity and the latest information on treatment strategies. After the update, Dr. Saxinger answers clinician questions on various aspects of COVID-19. Presenter:Lynora Saxinger, MD, FRCPC, CTropMedCochair, Scientific Advisory GroupAlberta COVID-19 Emergency Coordination CentreAssociate ProfessorDepartment of MedicineDivision of Infectious DiseasesUniversity of AlbertaEdmonton, AlbertCanadaContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0

In this episode, Part 8 of an ongoing series, Paul E. Sax, MD, provides a brief update on current treatment options for COVID-19. After the update, Dr. Sax answers clinician questions on various aspects of COVID-19.Presenter:Paul E. Sax, MDClinical Director HIV Program and Division of Infectious DiseasesBrigham and Women's HospitalProfessor of MedicineHarvard Medical SchoolBoston, MassachusettsContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3eDoJF0